AGÕæÈ˹ٷ½

STOCK TITAN

Waystar Announces Launch of Secondary Offering of Common Stock

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)

Waystar (NASDAQ: WAY), a healthcare payments software provider, has announced a secondary offering of 18 million shares of common stock. The offering is being conducted by existing shareholders including EQT AB, Bain Capital, and CPP Investments (the Selling Stockholders).

J.P. Morgan will serve as the underwriter for the offering, which will be made through a registration statement filed with the SEC. Importantly, Waystar will not receive any proceeds from this secondary offering as the company is not selling any shares directly.

Waystar (NASDAQ: WAY), fornitore di software per i pagamenti sanitari, ha annunciato un collocamento secondario di 18 milioni di azioni ordinarie. L'offerta è effettuata da azionisti esistenti, tra cui EQT AB, Bain Capital e CPP Investments (gli Azionisti Venditori).

J.P. Morgan agirà da sottoscrittore per l'operazione, che sarà eseguita tramite un prospetto depositato presso la SEC. È importante sottolineare che Waystar non riceverà proventi da questo collocamento secondario, poiché la società non vende azioni direttamente.

Waystar (NASDAQ: WAY), proveedor de software para pagos sanitarios, ha anunciado una colocación secundaria de 18 millones de acciones ordinarias. La oferta está siendo realizada por accionistas existentes, incluidos EQT AB, Bain Capital y CPP Investments (los Accionistas Vendedores).

J.P. Morgan actuará como suscriptor de la operación, que se llevará a cabo mediante una declaración de registro presentada ante la SEC. Es importante señalar que Waystar no recibirá ingresos por esta colocación secundaria, ya que la compañía no está vendiendo acciones directamente.

Waystar (NASDAQ: WAY), ì˜ë£Œ ê²°ì œ 소프트웨ì–� 제공업체가 보통ì£� 1800ë§� ì£�ì� 2ì°� 공모ë¥� 발표했습니다. ì´ë²ˆ 공모ëŠ� EQT AB, Bain Capital, CPP Investments ë“±ì„ í¬í•¨í•� 기존 주주(ë§¤ë„ ì£¼ì£¼ë“�)ê°€ 수행합니ë‹�.

J.P. Morganì� ì¸ìˆ˜ì¸ìœ¼ë¡� 참여하며, ì´ë²ˆ 공모ëŠ� SECì—� 제출ë� 등ë¡ì„œë¥˜ë¥� 통해 ì§„í–‰ë©ë‹ˆë‹�. 중요í•� ì ì€ WaystarëŠ� ì� 2ì°� 공모로부í„� ìžê¸ˆì� 받지 않습니다—회사가 ì§ì ‘ 주ì‹ì� íŒë§¤í•˜ì§€ 않기 때문입니ë‹�.

Waystar (NASDAQ: WAY), fournisseur de logiciels de paiement pour la santé, a annoncé une offre secondaire de 18 millions d'actions ordinaires. L'offre est réalisée par des actionnaires existants, notamment EQT AB, Bain Capital et CPP Investments (les Actionnaires Vendeurs).

J.P. Morgan agira en tant que souscripteur pour l'opération, qui se fera via une déclaration d'enregistrement déposée auprès de la SEC. Il est important de noter que Waystar ne percevra aucun produit de cette offre secondaire, la société ne vendant pas d'actions directement.

Waystar (NASDAQ: WAY), ein Anbieter von Software für Gesundheitszahlungen, hat eine Sekundärplatzierung von 18 Millionen Aktien Stammaktien angekündigt. Das Angebot wird von bestehenden Aktionären, darunter EQT AB, Bain Capital und CPP Investments (die verkaufenden Aktionäre), durchgeführt.

J.P. Morgan wird als Underwriter fungieren; die Platzierung erfolgt über eine bei der SEC eingereichte Registrierungserklärung. Wichtig ist, dass Waystar keine Erlöse aus dieser Sekundärplatzierung erhält, da das Unternehmen selbst keine Aktien verkauft.

Positive
  • None.
Negative
  • Large shareholders (EQT AB, Bain Capital, CPP Investments) are selling significant holdings, potentially indicating reduced confidence
  • 18 million share offering could create selling pressure on the stock

Insights

Major stockholders selling 18M shares in secondary offering; Waystar won't receive proceeds as company isn't selling shares.

This secondary offering of 18 million shares represents a significant transaction where EQT AB, Bain Capital, and Canada Pension Plan Investment Board (the original investors) are reducing their stake in Waystar. Importantly, this is strictly a secondary offering where existing shareholders are selling - Waystar itself isn't issuing new shares and won't receive any proceeds.

The structure signals these institutional investors are likely taking profits or rebalancing portfolios after holding positions since before Waystar's public listing. J.P. Morgan as the sole underwriter suggests a streamlined distribution process to institutional investors rather than a broader syndicated offering.

For current shareholders, this transaction has several implications. First, it introduces additional supply that could create temporary price pressure. Second, it enhances market float and potentially liquidity. Third, it represents a meaningful shift in ownership structure as these major stakeholders reduce their positions.

While secondary offerings often trigger short-term price adjustments, they can ultimately benefit long-term holders by increasing trading liquidity and broadening the investor base. The fact that these sophisticated institutional investors are selling a portion of their holdings provides valuable market information, though their continued involvement suggests they're not completely exiting their positions.

LEHI, Utah and LOUISVILLE, Ky., Sept. 10, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced that certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders") intend to offer for sale in an underwritten secondary offering 18,000,000 shares of common stock of Waystar pursuant to a registration statement filed by Waystar with the Securities and Exchange Commission (the "SEC").

The underwriter proposes to offer the shares of common stock to the public at a fixed price, which may be changed at any time without notice.ÌýWaystar is not selling any shares and will not receive any proceeds from the sale of shares in the offering by the Selling Stockholders.Ìý

J.P. Morgan is acting as the underwriter for the offering.

A registration statement on Form S-3 relating to these securities has been filed with the SEC and has become effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

The offering may be made only by means of a prospectus supplement and accompanying prospectus. Copies of the prospectus supplement and accompanying prospectus may be obtained by contacting: J.P. Morgan Securities LLC, Attention: c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or email: [email protected] and [email protected].ÌýYou may also obtain these and the other documents referred to above for free by visiting the SEC's website at .Ìý

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations and are inherently subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks and uncertainties include, but are not limited to, risks and uncertainties associated with the consummation of the offering and other risks described in Waystar's Annual Report on Form 10-K for the year ended December 31, 2024 and any subsequent filings with the SEC. Except as required by law, Waystar has no obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.

About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities.Ìý

Media Contact
Kristin Lee
[email protected]

Investor Contact
[email protected]

Cision View original content to download multimedia:

SOURCE Waystar

FAQ

How many shares are being offered in Waystar's (WAY) secondary offering?

The Selling Stockholders are offering 18,000,000 shares of Waystar common stock in the secondary offering.

Will Waystar (WAY) receive any proceeds from the secondary offering?

No, Waystar will not receive any proceeds from the offering as the company is not selling any shares. The proceeds will go to the selling stockholders.

Who are the selling stockholders in Waystar's secondary offering?

The selling stockholders are investment funds of EQT AB, Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments) and their affiliates.

Who is the underwriter for Waystar's (WAY) secondary offering?

J.P. Morgan is acting as the sole underwriter for the secondary offering.

How can investors participate in Waystar's (WAY) secondary offering?

Investors can obtain the prospectus supplement and accompanying prospectus through J.P. Morgan Securities LLC or by visiting the SEC's website at www.sec.gov.
Waystar Holding Corp.

NASDAQ:WAY

WAY Rankings

WAY Latest News

WAY Latest SEC Filings

WAY Stock Data

7.12B
121.20M
1.35%
102.38%
2.45%
Health Information Services
Services-computer Integrated Systems Design
United States
LEHI